Seah, Jo-An, et al. “Neoadjuvant Chemotherapy (NC) Should Be Administered to Fit Patients With Newly Diagnosed, Potentially Resectable Muscle-Invasive Urothelial Cancer (MIUC) of the Bladder – A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process”. Canadian Urological Association Journal, vol. 7, no. 9-10, Oct. 2013, pp. 312-8, doi:10.5489/cuaj.1506.